» Articles » PMID: 37448518

Extrachromosomal DNA (ecDNA) in Cancer: Mechanisms, Functions, and Clinical Implications

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Jul 14
PMID 37448518
Authors
Affiliations
Soon will be listed here.
Abstract

Extrachromosomal DNA (ecDNA) is circular DNA that plays an important role in the development and heterogeneity of cancer. The rapid evolution of methods to detect ecDNA, including microscopic and sequencing approaches, has greatly enhanced our knowledge of the role of ecDNA in cancer development and evolution. Here, we review the molecular characteristics, functions, mechanisms of formation, and detection methods of ecDNA, with a focus on the potential clinical implications of ecDNA in cancer. Specifically, we consider the role of ecDNA in acquired drug resistance, as a diagnostic and prognostic biomarker, and as a therapeutic target in the context of cancer. As the pathological and clinical significance of ecDNA continues to be explored, it is anticipated that ecDNA will have broad applications in the diagnosis, prognosis, and treatment of patients with cancer.

Citing Articles

The viral landscape in metastatic solid cancers.

Mjelle R, Castro I, Aass K Heliyon. 2025; 11(4):e42548.

PMID: 40028540 PMC: 11870251. DOI: 10.1016/j.heliyon.2025.e42548.


The distribution of the extrachromosomal DNA molecules in early lung cancer.

Fang J, Ying L, Ma Z, Yang Y, Zhu R, Su D Sci Prog. 2024; 107(3):368504241276771.

PMID: 39228317 PMC: 11375654. DOI: 10.1177/00368504241276771.


Multiple HPV integration mode in the cell lines based on long-reads sequencing.

Cui X, Li Y, Zhang C, Qi Y, Sun Y, Li W Front Microbiol. 2024; 14:1294146.

PMID: 38169727 PMC: 10758443. DOI: 10.3389/fmicb.2023.1294146.

References
1.
Burrell R, McGranahan N, Bartek J, Swanton C . The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013; 501(7467):338-45. DOI: 10.1038/nature12625. View

2.
Utani K, Fu H, Jang S, Marks A, Smith O, Zhang Y . Phosphorylated SIRT1 associates with replication origins to prevent excess replication initiation and preserve genomic stability. Nucleic Acids Res. 2017; 45(13):7807-7824. PMC: 5570034. DOI: 10.1093/nar/gkx468. View

3.
Cristofanilli M, Budd G, Ellis M, Stopeck A, Matera J, Miller M . Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004; 351(8):781-91. DOI: 10.1056/NEJMoa040766. View

4.
Von Hoff D, Forseth B, Clare C, Hansen K, VanDevanter D . Double minutes arise from circular extrachromosomal DNA intermediates which integrate into chromosomal sites in human HL-60 leukemia cells. J Clin Invest. 1990; 85(6):1887-95. PMC: 296655. DOI: 10.1172/JCI114650. View

5.
Gibaud A, Vogt N, Hadj-Hamou N, Meyniel J, Hupe P, Debatisse M . Extrachromosomal amplification mechanisms in a glioma with amplified sequences from multiple chromosome loci. Hum Mol Genet. 2010; 19(7):1276-85. DOI: 10.1093/hmg/ddq004. View